Compare BDSX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDSX | CHMI |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Precision Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.0M | 98.5M |
| IPO Year | 2020 | N/A |
| Metric | BDSX | CHMI |
|---|---|---|
| Price | $14.87 | $2.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $32.50 | $3.00 |
| AVG Volume (30 Days) | 131.3K | ★ 188.8K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.60% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,499,000.00 | N/A |
| Revenue This Year | $25.26 | N/A |
| Revenue Next Year | $19.70 | $59.20 |
| P/E Ratio | ★ N/A | $139.30 |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $0.25 | $2.17 |
| 52 Week High | $20.21 | $3.58 |
| Indicator | BDSX | CHMI |
|---|---|---|
| Relative Strength Index (RSI) | 48.80 | 58.14 |
| Support Level | $6.33 | $2.52 |
| Resistance Level | $20.21 | $2.76 |
| Average True Range (ATR) | 1.49 | 0.06 |
| MACD | -0.54 | 0.01 |
| Stochastic Oscillator | 8.41 | 76.65 |
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.